Topical tacrolimus for the amelioration of breast cancer-related lymphedema (TACLE Trial): a study protocol for a randomized, double-blind, placebo-controlled phase II/III trial
This trial is registered with the EU Clinical Trials Information System (CTIS) under EU CT Number: 2023-503644 - 13-00 (approved 16.05.2024) and ClinicalTrials.gov under identifier NCT06306274 (registered 12.03.2024).
Authors
- Mads Gustaf Jørgensen (ORCID: https://orcid.org/0000-0002-8755-3446)
- Frederik Gulmark Hansen (ORCID: https://orcid.org/0000-0002-4588-8053)
- Jens Ahm Sørensen (ORCID: https://orcid.org/0000-0003-4903-0094)
- Jørn Bo Thomsen (ORCID: https://orcid.org/0000-0002-7368-6133)
Institutions
- University of Southern Denmark (DK)
- Odense University Hospital (DK)
Publication Details
- Journal
- Trials
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1186/s13063-025-08829-3
- Citations
- 2
- Primary Topic
- Lymphatic System and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.09
Funders
- Dagmar Marshalls Fond
- Kræftens Bekæmpelse
- Dansk Kræftforsknings Fond
- Syddansk Universitet
- Lægeforeningen
- Else og Mogens Wedell Wedellsborgs Fond
- Simon Spies Fonden